WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment. [electronic resource]
Producer: 20020205Description: 19-23 p. digitalISSN:- 0169-4197
- Amifostine -- administration & dosage
- Animals
- Deoxycytidine -- adverse effects
- Drug Administration Schedule
- Female
- Jejunum -- drug effects
- Mice
- Mice, Inbred C3H
- Radiation-Protective Agents -- administration & dosage
- Radiation-Sensitizing Agents -- adverse effects
- Whole-Body Irradiation -- adverse effects
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.